+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Recent Advances in Life Science Technologies

  • ID: 4308232
  • Report
  • May 2017
  • Region: Global
  • 15 pages
  • Frost & Sullivan
1 of 2
This edition of the Genetic Technology TOE depicts the current landscape and the new life sciences trends across different technologies, including genetic testing for cancer, exosome technology capabilities, and gene delivery approaches.

The Genetic Technology TechVision Opportunity Engine (TOE) presents the latest R&D developments and advances with an emphasis on opportunities to profit in the explosive field of genetic technology through technology transfer, joint ventures, and acquisitions. The complete gamut of genetic technology applications is covered including the latest developments in omics technologies; genetic, cellular, and alternative therapies; sequencing technologies; and genetically altered animals and plants.

The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare.
Note: Product cover images may vary from those shown
2 of 2
Innovations in Life Science Technologies
  • Hereditary Cancer Risk Assessment Using 30-gene Test
  • New Age Companies Aid in Drug Discovery Needs of Pharmaceuticals
  • Diversified Stem Cell Lines to Increase Therapeutics across Major Disease Areas
  • Addressing Age-related Diseases through Telomerase Reverse Transcriptase Gene Delivery
Exosome Research Analysis and Industry Interactions
  • Exosome Technology Capability
  • Industry Interactions
Note: Product cover images may vary from those shown
3 of 2